Raloxifene safe for women with kidney disease

NEW YORK (Reuters Health) - Treatment with raloxifene safely increases bone mineral density in postmenopausal women with chronic kidney disease, and also lowers their risk of vertebral fractures, according to an analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial.

Continue to Raloxifene safe for women with kidney disease on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz